We are focused on a singular mission – improving the life quality of patients worldwide.
CANNASEN® is the efficient and safe OTC (over-the-counter) alternative that offers a safe and efficient solution enriched with the therapeutic properties of cannabinoids. Our products, registered as medical devices, harness the immense potential of cannabinoids to provide remarkable benefits. This innovative approach to medicine draws inspiration from a long history dating back to 4000 BC, where CBD usage in medicine has demonstrated proven success. With a solid legal foundation in place, we are able to tap into these ancient roots and develop products that feature an optimized concentration of crystalized CBD. This allows us to deliver high-quality, world-changing solutions to individuals suffering from autoimmune and stress-related disorders. By leveraging the power of cannabinoids, we aim to bring relief and transformative experiences to those in need, improving their overall well-being.
Is full of polarities, merging Nature and Science, the South and the North, the East and the West, the Past and the Future.
This story started in 2011, when two Danish sisters, Lone and Gitte: a Scientist and an Economist, started to realize the healing potential of the Cannabis sativa L. In 2015 their investigations brought them to Los Angeles, USA, where they studied the ancient CBD-based formulas used by wise Mexican women for generations. Their further investigation took them to Instituto Neurologico Buenos Aires, Argentina, India, and Germany where they partnered with Dr. Maria Augustina Duguine, Dr. Alejandro Andersson, Dr. Suresh, and Dr. Dauer early global experts in medical CBD usage, Medical Devices, and Food supplements.
Seeing the degree of the forgotten healing potential of the cannabinoids, the sisters decided to dedicate themselves to bringing the CBD-based treatment to European patients. Their first steps on the challenging CBD market required Scandinavian conscientiousness and sturdiness.
Our compliance culture is built on integrity, ethics, sound decision-making, and behaviors that sustain our values and commitment to patients and our customers.
We collaborate with our patients, our partners, and see ourselves as a part of a broad societal landscape. We are frank, through our words and our actions we show respect to our collaborators and the public at large. We were successfully inspected by the Danish Medicines Agency, endorsing that our performance indicator for overall Quality System (QMS) effectiveness is in place In 2022, we implemented the Greenlight system as part of our continuous quality improvement process. This upgrade enabled us to align our Standard Operating Procedures (SOPs) with the new Medical Device Regulation (MDR), ensuring compliance and regulatory adherence. Furthermore, we have implemented Post Market Surveillance and are actively in the queue for certification of our MDR products by the Notified Body. As a trusted resource, we remain steadfast in our commitment to delivering overall benefits and increased value in all our activities. Our strategic research endeavors focus on establishing trust and driving efficiency across all aspects of our operations, enabling us to maintain our strategic advantages in the market.